Showing results (1-10 of 384) with videos related to

Sort By:
Pageof 39
The World Journal of Men'S Health|January 17, 2023
Male Fertility and Physical ExerciseFederico Belladelli, Satvir Basran, Michael L Eisenberg
The World Journal of Men'S Health|February 15, 2023
Worldwide Temporal Trends in Penile Length: A Systematic Review and Meta-AnalysisFederico Belladelli, Francesco Del Giudice, Frank Glover, et al.
Fertility and Sterility|January 15, 2023
Reproduction as a window for health in menFederico Belladelli, Wade Muncey, Michael L Eisenberg
The World Journal of Men'S Health|September 1, 2022
The Association between Monthly, Yearly, and Lifetime Cannabis Use, and Semen Parameters in Asian-American MenFederico Belladelli, Tony Chen, Satvir Basran, et al.
European Urology Focus|September 10, 2023
The Association Between Insomnia, Insomnia Medications, and Erectile DysfunctionFederico Belladelli, Shufeng Li, Chiyuan A Zhang, et al.
The Journal of Sexual Medicine|October 20, 2023
Use of phosphodiesterase 5 inhibitors is not associated with ocular adverse eventsFederico Belladelli, Shufeng Li, Chiyuan A Zhang, et al.
Current Opinion in Urology|October 10, 2022
Counseling for the man with severe male infertilityFederico Belladelli, Wade Muncey, Nicolas Seranio, et al.
World Journal of Urology|August 7, 2023
5-alpha reductase inhibitors (5-ARi) with or without alpha-blockers (α-B) for Benign Prostatic Hyperplasia do NOT lower the risk of incident Bladder Cancer: United States insurance claims dataFrancesco Del Giudice, Federico Belladelli, Frank Glover, et al.
Reproductive Biomedicine Online|December 1, 2021
Male fertility as a marker for healthTony Chen, Federico Belladelli, Francesco Del Giudice, et al.
Urologic Oncology|September 7, 2024
5α-reductase inhibitors with or without alpha-blockers and risk of incident upper tract urothelial carcinoma in men with benign prostatic hyperplasia: Analysis of US insurance claims dataFrancesco Del Giudice, Łukasz Nowak, Frank Glover, et al.
Pageof 39